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Abstract 
Prothymosinα is a small molecular weight acidic protein ,and widely expressed 
in the body.ProTα evolutionarily conserved and Widely distributed. Its Molecular 
weight of 12.5k ,and gene located on chromosome 2. ProTα promoting immune 
function, another important function is to increase cell proliferation, cell growth and 
survival is essential;lack ProTα cells can not divide. ProTα associated with cell 
proliferation, and tumor cells with strong proliferative activity, thus ProTα role in 
tumor progression as the focus of research. ProTα involved in tumorigenesis, 
apoptosis and transcription regulation. The current study focused on the regulatory 
mechanisms of gene ProTα in cancer diagnosis and treatment of value. 
     As ProTα no secondary structure, immunogenicity is poor, it is difficult to 
prepare a monoclonal antibody, this study by ProTα carrier protein coupled with the 
small molecule KLH approach, and application of conventional genetic engineering 
methods to obtain fusion protein of GST-ProTα, then enhance the immunogenicity of 
ProTα .We prepared three kind of polyclonal antibodies against ProTα from rat,mice 
and rabbit respectively. By means of cell fluorescence immunohistochemistry, 
paraffin section immunohistochemistry, dot blot, Western-Blot and other methods 
used for these antibodies on lymphocyte, Renal tubular cells,tumor cells, tissue 
protein, human urine, pathological sections such as immunoaffinity detection. 
Preliminary study the relationship between ProTα and cell proliferation,and the 
expression of ProTα in tumor tissues, as well as the feasibility of ProTα as the tumor 
markers in the urinary system.    
The results showed that prepared high titer polyclonal antibodies with the antigen 
protein to produce strong specific binding. After a standard ProTα and bladder tumors, 
kidney tumors and urine detection of prostate cancer patients are able to specifically 
detect which ProTα . 
The detect possitive rate of bladder cancer was 100%, urinary tract inflammation 
and other diseases Urine detection possitive rate was 53.8%, only 9% of healthy urine, 
and showed significant weak spots. The detection lowest limit is 1ng/μL. As a 
screening tool, sensitivity and negative predictive is more important than the specific, 
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for further research. 
By means of dot blot methold to detect the ProTα of urine has the propertise with 
less reagent; simple, rapid and does not require special equipment conditions; in 
addition to, this methold also has non-invasive harmful; the test results can be stored 
for a long, easy to review; specificity and high sensitivity characteristics. These 
present results will benefit to study the  biological mechanism of ProTα ,it also has 
important theoretical significance and application value to prepare the effective tumor 
marker detection kit. 
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1  前言 
1.1  胸腺素 α原的概述 
1.1.1  ProTα的细胞定位与受体 
Haritos 等于1984年从大鼠胸腺分离出一种含有111个氨基酸残基的多肽，其













证据。Cordero[4]等研究发现在人淋巴母细胞膜表面存在着 2 类 ProTα受体，一类
是高亲和力受体，另一类为低亲和力受体。而另一类淋巴细胞 YT 淋巴细胞只有
高亲和力的 ProTα受体。研究还发现，ProTα是通过非 Tα1 序列与其受体结合的，
Tα1 对其没有竞争性抑制作用，但 ProTα抗体能拮抗这种结合，同时发现这种结
合与温度和时间有关。进一步研究发现，在 PHA 诱导的淋巴母细胞上存在的高
特异性受体主要是由相对分子质量分别为 31000、29000 和 19000 的 3 种蛋白所
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1.1.2  ProTα的结构特点 
ProTα 进化上高度保守，分布极其广泛，淋巴组织及非淋巴组织均可找到。
不仅富含于胸腺中，在多种组织中都能检测到，脾脏、淋巴组织、肝、肾、睾丸、
卵巢及脑等都有胸腺素 α 原 mRNA 信号[1]，尤其在免疫器官组织中，还有病变
体如肿瘤[6]。在一些未成熟的细胞以及年幼的个体中 ProTα的表达量也较高，通
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1.1.3  ProTα的功能 
ProTα具有两种不同的功能活性，即胞外的免疫调节活性和在胞内促进细胞
增殖的作用。许多体外和体内实验表明ProTα蛋白具有调节免疫和抗癌活性。 
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增强自然杀伤性细胞的活性。ProTα通过诱导 CD4+T淋巴细胞产生 IL-2 和
IL-2R（IL-2 受体），调节分泌 PGE2,从而恢复癌症病人受到抑制的 T淋巴细胞
的功能。ProTα还可以增强淋巴细胞对PHA刺激的反应活性，提高细胞的增殖反
应[33]。这些免疫调节作用的分子机制目前还不清楚，不过 近有报道，Tα1可以
通过 TLR（钟型受体）与 MyD88信号传导通路激活DC细胞，进而诱使 Th1细
胞产生抗真菌感染免疫[34]，或许ProTα也可以通过这种途径调节免疫。 
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